M&A Deal Summary

GTCR Acquires TranZact

On October 1, 2024, private equity firm GTCR acquired marketing company TranZact from Willis Towers Watson for 632M USD

Acquisition Highlights
  • This is GTCR’s 3rd transaction in the Marketing sector.
  • This is GTCR’s 8th largest (disclosed) transaction.
  • This is GTCR’s 137th transaction in the United States.
  • This is GTCR’s 3rd transaction in New Jersey.

M&A Deal Summary

Date 2024-10-01
Target TranZact
Sector Marketing
Buyer(s) GTCR
Sellers(s) Willis Towers Watson
Deal Type Divestiture
Deal Value 632M USD

Target

TranZact

Fort Lee, New Jersey, United States
TranZact specializes in addressing consumers' insurance needs through our comprehensive direct-to-consumer marketing, sales, servicing, and technology capabilities. TranZact was founded in 1997 and is based in Fort Lee, New Jersey.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GTCR

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 15.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. GTCR was formed in 1980 and is based in Chicago, Illinois.


DEAL STATS #
Overall 142 of 142
Sector (Marketing) 3 of 3
Type (Divestiture) 12 of 12
State (New Jersey) 3 of 3
Country (United States) 137 of 137
Year (2024) 3 of 3
Size (of disclosed) 8 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-29 SurModics

Eden Prairie, Minnesota, United States

SurModics provides surface modification coating technologies and in vitro diagnostic (IVD) products to the healthcare industry. Its two core businesses include: Medical Device Coatings – lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and advanced drug delivery systems; and In Vitro Diagnostics (IVD) – immunoassay reagents that improve the performance of in vitro diagnostic tests as well as custom coatings and stabilization products for Molecular Diagnostic applications. Surmodics was founded in 1979 and is based in Eden Prairie, Minnesota.

Buy $627M

Seller(S) 1

SELLER

Willis Towers Watson

London, United Kingdom

Category Company
Founded 1828
Sector Insurance
Employees48,000
Revenue 9.5B USD (2023)
DESCRIPTION

Willis Towers Watson is a global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. Willis designs and delivers solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Willis Towers Watson was founded in 1828 and is based in London, United Kingdom.


DEAL STATS #
Overall 3 of 3
Sector (Marketing) 1 of 1
Type (Divestiture) 3 of 3
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-06 Aerosure

Pyrmont, Australia

Aerosure is an aviation industry specialist that provides a suite of aviation insurance broking solutions to service the insurance and risk needs of the aviation industry in Australia and New Zealand, as well as the broader Asia Pacific region. Aerosure is based in Pyrmont, Australia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-03 atomos wealth

London, United Kingdom

atomos wealth is a wealth management firm offering a variety of services including investment management and financial planning advice. atomos wealth was formerly Sanlam Wealth and is based in London, United Kingdom.

Buy -